Products for Research Use Only
RegisterLogin

CDKI-73

CAT: 0957-S7773-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-S7773-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDKI-73 (LS-007) is a potent CDK inhibitor in vitro with IC50 of 8.17 nM, 3.27 nM, 8.18 nM, and 5.78 nM for CDK1, CDK2, CDK4, and CDK9, respectively. CDKI-73 induces apoptosis in cancer cells. CDKI-73 is an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia.
CAS Number
1421693-22-2
Target
CDK
Activity
Cell Cycle
Molecular Formula
C15H15FN6O2S2
Storage Conditions
3 years -20°C powder

Related Products

CatalogName
S0273-5mgCDK2-IN-73 (CDK2-IN-4)
S0273-10mM/1mLCDK2-IN-73 (CDK2-IN-4)
S0273-01CDK2-IN-73 (CDK2-IN-4)
S0273-25mgCDK2-IN-73 (CDK2-IN-4)
S0273-100mgCDK2-IN-73 (CDK2-IN-4)
E4693-01AC-73
S0026-25mgGET-73
S0026-1gGET-73
S0026-10mM/1mLGET-73
E4693-25mgAC-73

Alternative Products

CatalogName
T14919-01CDKI-73
A21467-100Asnuciclib (CDKI-73) 100mg
A21467-10Asnuciclib (CDKI-73) 10mg
A21467-5Asnuciclib (CDKI-73) 5mg
A21467-25Asnuciclib (CDKI-73) 25mg
A21467-50Asnuciclib (CDKI-73) 50mg
A21467-2Asnuciclib (CDKI-73) 2mg
A21467-1Asnuciclib (CDKI-73) 1mg
A21467-10mM-DAsnuciclib (CDKI-73) 10mM * 1mL in DMSO
MBS5811396CDKi Hydrochloride

Popular Products